Zika isn’t as deadly as many believe: expert says

Zika isn’t as deadly as many believe: expert says

The devastating Zika epidemic gained global attention in the last couple of years, but it in most cases it is actually a mild illness symptoms similar to that of common cold.

Participating in the First Friday talk held at The Cedars, Dr. Jonathan Frye, a renowned ecologist and natural science professor at Mac College, gave a presentation titled “The Epidemic Spread of the Zika Virus,” and spoke about various dangers, misnomers and myths about the virus.

Frye said Zika might have reached epidemic levels, but it isn’t typically deadly. Symptoms are hardly ever severe enough to require hospitalization, and Zika-related deaths are very rare. It is related to diseases like yellow fever, dengue and West Nile.

Speaking on the topic, he added, “There’s this whole family of diseases caused by a family of viruses. They share some common features, but have slight differences in how they work. It was not an epidemic at first, because there were so few cases.”

Zika virus was named after Uganda’s Zika forest, where it was first detected among monkeys in the late 1940s. The first case of Zika illness in humans was reported in 1952 in the African country of Nigeria.

Symptoms of Zika infection include fever, rash, pain in joints, muscle pain, red eyes, headache and fatigue, which usually last a few days to more than a week.

General: 

Popular Stories

Erosion of beaches will get worse: researchers warn

Portraying a gloomy picture of the future, the 2015... Read More

Rare rat-linked disease leaves 1 dead, 2 sickened in Bronx

A rare bacterial disease carried by rats has killed... Read More

Try drug-free remedies before resorting to medication for low back pain: ACP

People suffering low back pain should try drug-free... Read More

Pregnant inmate forced to deliver baby on jail cell floor

A Detroit-area sheriff has defended his staff over... Read More

Marathon Pharma to sell decades-old drug to treat DMD for $89,000

Marathon Pharmaceuticals will reportedly market... Read More